01276 恒瑞醫藥
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
24/11/2025The Goldman Sachs Group, Inc.1004(L)+5,897,341(L)15,075,062(L)
4,661,600(S)		5.84
1.81
21/11/2025Morgan Stanley1311(L)1,436,600(L)17,746,846(L)
15,007,752(S)
0(P)		6.87
5.81
0.00
21/11/2025Morgan Stanley1101(L)+1,330,464(L)HKD 66.734(L)19,077,310(L)
14,816,229(S)
0(P)		7.38
5.73
0.00
20/11/2025GIC Private Limited1101(L)+952,000(L)HKD 68.798(L)57,665,600(L)22.33
20/11/2025UBS Group AG1113(L)+1,000,000(L)16,304,750(L)
4,276,867(S)		6.31
1.66
20/11/2025Morgan Stanley1305(L)1,172,756(L)16,458,497(L)
14,734,847(S)
0(P)		6.37
5.70
0.00
19/11/2025Morgan Stanley1311(L)319,897(L)16,748,549(L)
14,632,576(S)
0(P)		6.48
5.66
0.00
18/11/2025Morgan Stanley1311(L)206,459(L)15,361,798(L)
14,679,433(S)
0(P)		5.94
5.68
0.00
18/11/2025Morgan Stanley1101(L)+1,386,751(L)HKD 71.516(L)16,748,549(L)
14,632,576(S)
0(P)		6.48
5.66
0.00
17/11/2025Morgan Stanley1306(L)892,282(L)15,514,206(L)
14,069,672(S)
0(P)		6.00
5.44
0.00
17/11/2025UBS Group AG1402(S)+69,600(S)14,750,362(L)
2,614,041(S)		5.71
1.01
17/11/2025Morgan Stanley1201(L)-152,408(L)HKD 72.425(L)15,361,798(L)
14,679,433(S)
0(P)		5.94
5.68
0.00
14/11/2025Morgan Stanley1311(L)35,600(L)15,482,832(L)
14,007,102(S)
0(P)		5.99
5.42
0.00
14/11/2025Morgan Stanley1113(L)+31,374(L)15,514,206(L)
14,069,672(S)
0(P)		6.00
5.44
0.00
13/11/2025Morgan Stanley1311(L)54,200(L)14,332,733(L)
13,169,913(S)
0(P)		5.55
5.10
0.00
12/11/2025Morgan Stanley1306(L)61,700(L)14,853,608(L)
12,957,942(S)
0(P)		5.75
5.01
0.00
11/11/2025Morgan Stanley1402(S)+348,092(S)14,853,608(L)
12,957,942(S)
0(P)		5.75
5.01
0.00
11/11/2025Citigroup Inc.1403(S)+117,858(S)14,757,418(L)
13,011,622(S)
7,769,933(P)		5.71
5.03
3.00
11/11/2025Morgan Stanley1306(L)368,800(L)14,522,684(L)
12,609,850(S)
0(P)		5.62
4.88
0.00
10/11/2025Morgan Stanley1502(S)-437,214(S)14,522,684(L)
12,609,850(S)
0(P)		5.62
4.88
0.00
10/11/2025Morgan Stanley1306(L)79,500(L)14,985,880(L)
13,047,064(S)
0(P)		5.80
5.05
0.00
08/11/2025冯佶1213(L)-120,000(L)330,000(L)0.01
07/11/2025孙杰平1113(L)+70,000(L)1,851,992(L)0.03
07/11/2025冯佶1113(L)+180,000(L)450,000(L)0.01
07/11/2025张连山1113(L)+120,000(L)803,152(L)0.01
07/11/2025戴洪斌1113(L)+150,000(L)2,086,842(L)0.03
07/11/2025Citigroup Inc.1316(L)+1,051,226(L)14,295,026(L)
12,441,186(S)
7,769,933(P)		5.53
4.81
3.00
07/11/2025Morgan Stanley1305(L)531,000(L)14,781,481(L)
12,906,260(S)
0(P)		5.72
4.99
0.00
07/11/2025The Bank of New York Mellon Corporation1013(L)+13,194,600(L)17,939,475(L)
17,939,475(P)		6.95
6.95
07/11/2025江宁军1113(L)+120,000(L)306,000(L)0.00
07/11/2025Morgan Stanley1402(S)+140,804(S)14,985,880(L)
13,047,064(S)
0(P)		5.80
5.05
0.00
07/11/2025徐煜1113(L)+4,000(L)10,400(L)0.00
06/11/2025Citigroup Inc.1013(L)
1403(S)		+694,400(L)
+235,070(S)		HKD 0.000(L)13,189,600(L)
12,314,335(S)
6,860,178(P)		5.10
4.76
2.65
06/11/2025Morgan Stanley1305(L)1,152,026(L)15,469,174(L)
12,863,413(S)
0(P)		5.99
4.98
0.00
05/11/2025Citigroup Inc.1704(L)-894,259(L)HKD 0.000(L)12,495,200(L)
12,079,265(S)
6,259,261(P)		4.83
4.67
2.42
05/11/2025UBS Group AG1213(L)
1502(S)		-955,300(L)
-955,300(S)		15,232,911(L)
2,226,584(S)		5.90
0.86
05/11/2025Morgan Stanley1201(L)-108,732(L)HKD 73.702(L)15,469,174(L)
12,863,413(S)
0(P)		5.99
4.98
0.00
05/11/2025Morgan Stanley1306(L)1,994,643(L)15,577,906(L)
12,448,121(S)
0(P)		6.03
4.82
0.00
04/11/2025Citigroup Inc.1013(L)
1403(S)		+1,308,042(L)
+149,833(S)		HKD 0.000(L)13,389,459(L)
11,403,086(S)
7,800,304(P)		5.18
4.41
3.02
04/11/2025UBS Group AG1306(L)1,840,374(L)17,067,004(L)
3,810,477(S)		6.61
1.48
  1    2   3    4    5    6    7    8  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.